The Ambry Test: CUL4B-Related XLMR includes gene sequence analysis of the CUL4B gene. Testing is also available for individual mutations in families in which a specific CUL4B mutation has previously been identified.
The Ambry Test: CUL4B-Related XLMR includes gene sequence analysis of the CUL4B gene. Testing is also available for individual mutations in families in which a specific CUL4B mutation has previously been identified.
Next-Gen Sequencing of CUL4B is also available as part of Ambry's XLMR Next-Gen SuperPanel™. It cannot be ordered separately.
Mental retardation (MR) involves a complex collection of clinically and genetically diverse disorders. Diagnosis of MR is typically based on three main criteria: onset of symptoms before the age of 18, intellectual abilities significantly lower than average, and reduced adaptive skills. Individuals with MR tend to struggle in areas including communication, health, interpersonal/social skills, leisure, safety, self-guidance and care, school performance, and work.
X-linked mental retardation (XLMR) is associated with more than 200 conditions linked to >90 genes on the X chromosome. XLMR affects approximately 1/600-1/1000 males, as well as a significant number of females. Mutations in these genes have been shown to be an underlying cause of mental retardation, which may or may not be associated with other congenital anomalies, developmental delay, autism, dysmorphism, and numerous genetic syndromes. One of the XLMR associated genes is CUL4B.
CUL4B encodes a protein subunit that forms the Cullin-RING ubiqutin ligase complex and participates in ubiquitin-dependent protein degradation. This fundamental cellular process has been implicated in cell cycle, immune response, and development. The CUL4B gene is located at Xq24 and contains 22 exons. Missense/nonsense mutations, small and gross deletions, and splicing mutations have been reported in CUL4B. The main clinical features of patients with mutations in CUL4B include mental retardation, aggressive outbursts, tremor, central obesity, and hypogonadism (Tarpey PS et al. Am J Hum Genet. 2007;80:345-352).
CUL4B genetic testing may be considered for any individual with idiopathic syndromic or non-syndromic mental retardation, developmental delay, and learning disabilities with or without congenital abnormalities.
Carrier testing for at-risk family members and prenatal testing are available for families in which a specific mutation in CUL4B has been identified.
Genomic deoxyribonucleic acid (gDNA) is isolated from the patient’s specimen using a standardized kit and quantified by agarose gel electrophoresis. If gene sequence analysis is requested, all the analyzed regions of the gene are amplified through polymerase chain reaction (PCR) and the exact nature of the gene’s sequence variation(s) can be identified through double-stranded sequencing from sense and anti-sense directions. If specific mutation analysis is requested, only specific region(s) of DNA is (are) amplified by PCR and sequenced. CUL4B exons 1-22 plus at least 20 bases into the 5’ and 3’ ends of all the introns are analyzed. The following sites are used to search for previously described CUL4B mutations and polymorphisms: Human Gene Mutation Database (HGMD) and online search engines (e.g., PubMed).
| Test Code | Technique | CPT Codes |
|---|---|---|
| 3220 | CUL4B Gene Sequence Analysis | 83891x1, 83894x22, 83898x21, 83904x42, 83909x42, 83912x1 |
| Technique | Days |
|---|---|
| CUL4B Gene Sequence Analysis | 21-35 |